Xie L. Xu

Identification of a RING protein that can interact in vivo with the BRCA1 gene product

Leeju C. Wu, Zhuo Wei Wang, Julia Tsou Tsan et al. · Nature Genetics · 1996 · 752 citations

Life Sciences, Genetics, Molecular Biology +11

Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial

Philip J. Mease, Proton Rahman, Alice B. Gottlieb et al. · The Lancet · 2020 · 344 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9

Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial

Atul Deodhar, Philip Helliwell, Wolf‐­Henning Boehncke et al. · The Lancet · 2020 · 322 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

Atul Deodhar, Alice B. Gottlieb, Wolf‐­Henning Boehncke et al. · The Lancet · 2018 · 184 citations

Medicine, Clinical Sciences, Pharmacotherapy +7

Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains

Ying Jin, Xie L. Xu, Meng-Chun W. Yang et al. · Proceedings of the National Academy of Sciences · 1997 · 163 citations

Life Sciences, Cell Biology, Molecular Biology +17